219 related articles for article (PubMed ID: 25219937)
1. Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS.
Samara MT; Engel RR; Millier A; Kandenwein J; Toumi M; Leucht S
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1767-72. PubMed ID: 25219937
[TBL] [Abstract][Full Text] [Related]
2. Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia.
Suzuki T; Uchida H; Sakurai H; Ishizuki T; Tsunoda K; Takeuchi H; Mimura M
Psychiatry Res; 2015 Jun; 227(2-3):265-9. PubMed ID: 25882098
[TBL] [Abstract][Full Text] [Related]
3. Linking the PANSS, BPRS, and CGI: clinical implications.
Leucht S; Kane JM; Etschel E; Kissling W; Hamann J; Engel RR
Neuropsychopharmacology; 2006 Oct; 31(10):2318-25. PubMed ID: 16823384
[TBL] [Abstract][Full Text] [Related]
4. Equipercentile linking of the BPRS and the PANSS.
Leucht S; Rothe P; Davis JM; Engel RR
Eur Neuropsychopharmacol; 2013 Aug; 23(8):956-9. PubMed ID: 23433639
[TBL] [Abstract][Full Text] [Related]
5. One-year functional outcomes of naturalistically treated patients with schizophrenia.
Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
[TBL] [Abstract][Full Text] [Related]
6. Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis.
Siafis S; Brandt L; McCutcheon RA; Gutwinski S; Schneider-Thoma J; Bighelli I; Kane JM; Arango C; Kahn RS; Fleischhacker WW; McGorry P; Carpenter WT; Falkai P; Hasan A; Marder SR; Schooler N; Engel RR; Honer WG; Buchanan RW; Davidson M; Weiser M; Priller J; Davis JM; Howes OD; Correll CU; Leucht S
Lancet Psychiatry; 2024 Jan; 11(1):36-46. PubMed ID: 38043562
[TBL] [Abstract][Full Text] [Related]
7. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Personal and Social Performance (PSP) Scale in a German sample of acutely ill patients with schizophrenia.
Juckel G; Schaub D; Fuchs N; Naumann U; Uhl I; Witthaus H; Hargarter L; Bierhoff HW; Brüne M
Schizophr Res; 2008 Sep; 104(1-3):287-93. PubMed ID: 18595665
[TBL] [Abstract][Full Text] [Related]
9. Linking PANSS negative symptom scores with the Clinical Global Impressions Scale: understanding negative symptom scores in schizophrenia.
Leucht S; Barabássy Á; Laszlovszky I; Szatmári B; Acsai K; Szalai E; Harsányi J; Earley W; Németh G
Neuropsychopharmacology; 2019 Aug; 44(9):1589-1596. PubMed ID: 30836381
[TBL] [Abstract][Full Text] [Related]
10. Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia.
Lee J; Fervaha G; Takeuchi H; Powell V; Remington G
J Clin Psychopharmacol; 2015 Jun; 35(3):237-41. PubMed ID: 25839337
[TBL] [Abstract][Full Text] [Related]
11. Examination of the Positive and Negative Syndrome Scale factor structure and longitudinal relationships with functioning in early psychosis.
Best MW; Grossman M; Oyewumi LK; Bowie CR
Early Interv Psychiatry; 2016 Apr; 10(2):165-70. PubMed ID: 25277757
[TBL] [Abstract][Full Text] [Related]
12. Reliability and validity of DSM-IV Axis V scales in a clinical sample of veterans with posttraumatic stress disorder.
Jovanović AA; Gasić MJ; Ivković M; Milovanović S; Damjanović A
Psychiatr Danub; 2008 Sep; 20(3):286-300. PubMed ID: 18827754
[TBL] [Abstract][Full Text] [Related]
13. Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia.
Apiquian R; Elena Ulloa R; Herrera-Estrella M; Moreno-Gómez A; Erosa S; Contreras V; Nicolini H
Schizophr Res; 2009 Jul; 112(1-3):181-6. PubMed ID: 19398302
[TBL] [Abstract][Full Text] [Related]
14. Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI.
Levine SZ; Rabinowitz J; Engel R; Etschel E; Leucht S
Schizophr Res; 2008 Jan; 98(1-3):318-22. PubMed ID: 17949948
[TBL] [Abstract][Full Text] [Related]
15. Validation of a Clinical Global Impression Scale for Aggression (CGI-A) in a sample of 558 psychiatric patients.
Huber CG; Lambert M; Naber D; Schacht A; Hundemer HP; Wagner TT; Schimmelmann BG
Schizophr Res; 2008 Mar; 100(1-3):342-8. PubMed ID: 18255271
[TBL] [Abstract][Full Text] [Related]
16. Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study.
Schennach-Wolff R; Obermeier M; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Engel RR; Möller HJ; Riedel M
J Clin Psychopharmacol; 2010 Dec; 30(6):726-31. PubMed ID: 21105273
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
Ratner Y; Gibel A; Yorkov V; Ritsner MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1401-9. PubMed ID: 17669574
[TBL] [Abstract][Full Text] [Related]
18. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
Chino B; Nemoto T; Fujii C; Mizuno M
Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
[TBL] [Abstract][Full Text] [Related]
19. Relationship of depression with cognitive insight and socio-occupational outcome in patients with schizophrenia.
Grover S; Sahoo S; Nehra R; Chakrabarti S; Avasthi A
Int J Soc Psychiatry; 2017 May; 63(3):181-194. PubMed ID: 28162014
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the minimum clinically important difference in quality of life in schizophrenia measured by the Quality of Well-Being Scale and disease-specific measures.
Thwin SS; Hermes E; Lew R; Barnett P; Liang M; Valley D; Rosenheck R
Psychiatry Res; 2013 Oct; 209(3):291-6. PubMed ID: 23473656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
